Novavax says COVID-19 vaccine 89% effective in UK trial, less in South Africa, shares jump

Novavax Inc said on Thursday its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the UK, according to a preliminary...

reuters.com